Robustness in Regulated Bioanalysis: A 30,000 Injection Study of Naltrexone in Human Plasma using the Xevo™ TQ Absolute XR Mass Spectrometer

Application Note A 30,000 Injection Assessment of Xevo™ TQ Absolute XR Mass Spectrometer Quantitative Stability and Uptime for Analysis of Naltrexone for Clinical Research Henry Foddya, David Farrellb, Sally Hannamb, Peter Hancocka, Nikunj Tannac, Robert S. Plumbc a Waters Corporation,…

Application Note Xevo TQ Absolute XR: Maximum Robustness and Sensitivity For High-Throughput Bioanalysis Robert S. Plumb Waters Corporation, United States Published on June 02, 2025 Contact Sales Abstract The accurate LC-MS/MS quantification of candidate pharmaceuticals, their metabolites and biomarkers in…

Application Note mAbs Testing in Inflammation Using Mass Spectrometry – Combination of mAbXmise™ Kits and XEVO™ TQ Absolute XR Mass Spectrometer Davor Fielitza, Dorothée Lebertb a Waters Corporation, Eschborn, Germany b Promise Proteomics, Grenoble, France Published on February 18, 2026…

Application Note A Streamlined Workflow for Quantitative Bioanalysis using waters_connect for Quantitation Software: A Case Study Using Gefitinib Robert Plumb Waters Corporation, United States Published on November 20, 2025 Abstract Preclinical and early human drug metabolism and pharmacokinetics (DMPK) studies…